Efficacy and Safety of the Biosimilar Recombinant Human Parathyroid Hormone Cinnopar® in Postmenopausal Osteoporotic Women: A Randomized Double-blind Clinical Trial

by Ozra TABATABAEI-MALAZY, Masumeh NORANI, Ramin HESHMAT, Mostafa QORBANI, Afsaneh VOSOOGH, Behnaz AFRASHTEH, Farzin KAHKESHAN, Arman AJAMI, Bagher LARIJANI
Published 2018-08-01